Literature DB >> 2916046

Human neoplasm pH and response to radiation therapy: P-31 MR spectroscopy studies in situ.

T C Ng1, A W Majors, S Vijayakumar, N J Baldwin, F J Thomas, I Koumoundouros, M E Taylor, S F Grundfest, T F Meaney, R R Tubbs.   

Abstract

Thirty-five human neoplasms from various sites and of various histologic types and stages were examined with phosphorus-31 magnetic resonance spectroscopy in situ. The tumors included 13 squamous cell carcinomas of the head and neck (lymph nodes), eight Hodgkin lymphomas, six non-Hodgkin lymphomas, four carcinomas of the breast, one melanoma, one sarcoma, one neuroblastoma, and one mucoepidermoid sarcoma of the salivary glands. Thirty-four of the neoplasms had normal to slightly alkaline pH before irradiation. During fractionated radiation therapy, the pH stayed in a range of from near neutral to alkaline and rose to 7.6-8.0 at several time points of radiation therapy for some tumors. These results suggest that most tumor cells in human neoplasms are well oxygenated and that only a negligible fraction are chronic hypoxic cells. The fluctuating alkaline pH during radiation therapy occurred regardless of the responsiveness of the treated tumors.

Entities:  

Mesh:

Year:  1989        PMID: 2916046     DOI: 10.1148/radiology.170.3.2916046

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  11 in total

Review 1.  Manipulating extracellular tumour pH: an effective target for cancer therapy.

Authors:  Guanyu Hao; Zhi Ping Xu; Li Li
Journal:  RSC Adv       Date:  2018-06-19       Impact factor: 4.036

2.  The role of lysosomes in limiting drug toxicity in mice.

Authors:  Rosemary A Ndolo; M Laird Forrest; Jeffrey P Krise
Journal:  J Pharmacol Exp Ther       Date:  2010-01-07       Impact factor: 4.030

3.  Clinical applicability of human in vivo localized phosphorus-31 magnetic resonance spectroscopy of bone and soft tissue tumors.

Authors:  H J Hoekstra; W J Boeve; R L Kamman; E L Mooyaart
Journal:  Ann Surg Oncol       Date:  1994-11       Impact factor: 5.344

4.  Metabolites of alveolar Echinococcus as determined by [31P]- and [1H]-nuclear magnetic resonance spectroscopy.

Authors:  M Novak; N Hameed; R Buist; B J Blackburn
Journal:  Parasitol Res       Date:  1992       Impact factor: 2.289

5.  (31)P CSI of the human brain in healthy subjects and tumor patients at 9.4 T with a three-layered multi-nuclear coil: initial results.

Authors:  Christian Mirkes; Gunamony Shajan; Grzegorz Chadzynski; Kai Buckenmaier; Benjamin Bender; Klaus Scheffler
Journal:  MAGMA       Date:  2016-01-25       Impact factor: 2.310

6.  Acidosis Sensing Receptor GPR65 Correlates with Anti-Apoptotic Bcl-2 Family Member Expression in CLL Cells: Potential Implications for the CLL Microenvironment.

Authors:  Ashley E Rosko; Karen S McColl; Fei Zhong; Christopher B Ryder; Ming-Jin Chang; Abdus Sattar; Paolo F Caimi; Brian T Hill; Sayer Al-Harbi; Alexandru Almasan; Clark W Distelhorst
Journal:  J Leuk (Los Angel)       Date:  2014-12

7.  Acid gradient across plasma membrane can drive phosphate bond synthesis in cancer cells: acidic tumor milieu as a potential energy source.

Authors:  Gautam Dhar; Suvajit Sen; Gautam Chaudhuri
Journal:  PLoS One       Date:  2015-04-15       Impact factor: 3.240

8.  Application of 31P MR spectroscopy to the brain tumors.

Authors:  Dong-Ho Ha; Sunseob Choi; Jong Young Oh; Seong Kuk Yoon; Myong Jin Kang; Ki-Uk Kim
Journal:  Korean J Radiol       Date:  2013-05-02       Impact factor: 3.500

9.  The assessment of treatment response in non-Hodgkin's lymphoma by image guided 31P magnetic resonance spectroscopy.

Authors:  S R Smith; P A Martin; J M Davies; R H Edwards; A N Stevens
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640

10.  Establishing upper limits on neuronal activity-evoked pH changes with APT-CEST MRI at 7 T.

Authors:  Vitaliy Khlebnikov; Jeroen C W Siero; Alex A Bhogal; Peter R Luijten; Dennis W J Klomp; Hans Hoogduin
Journal:  Magn Reson Med       Date:  2017-11-20       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.